RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma

The present study was designed to investigate the association between response evaluation criteria in solid tumors (RECIST) 1.1 and 1.0, and to explore the utility of thyroglobulin (Tg) measurements in assessing tumor responses to sorafenib in patients with radioactive iodine (RAI)-refractory differ...

Descripción completa

Detalles Bibliográficos
Autores principales: RUAN, MAOMEI, SHEN, YAN, CHEN, LIBO, LI, MINGHUA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789091/
https://www.ncbi.nlm.nih.gov/pubmed/24137351
http://dx.doi.org/10.3892/ol.2013.1424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789091/
https://www.ncbi.nlm.nih.gov/pubmed/24137351
http://dx.doi.org/10.3892/ol.2013.1424

Ejemplares similares